Skip to content


The CAR-TCR series is dedicated to the safe, effective, affordable, clinical and commercial development of CAR and TCR based cell therapies in oncology and beyond.

Our focused and comprehensive forums are the definitive platforms for scientific and business leaders from pharma, biotech & academia to discuss basic early science through to late stage commercialization challenges to deliver on the promise of personalized therapies for patients globally.

“Having attended both CAR-TCR Summits in both Shanghai and Boston this year, and seeing the list of attendees and amazing coordination by Hanson Wade at both events, I'm convinced this is the most relevant and important CAR-TCR series for the coming years.”

Syneos Health